Randomised controlled trial of HPV self-sampling for improving participation in cervical screening: the iPAP trial
Grant number: 1045346 | Funding period: 2013 - 2015
Effectiveness of cervical cancer screening relies on maximising participation. Unlike a Pap test, an HPV test may be self-collected and this may overcome some of the barriers to Pap testing. Overseas trials have found higher uptake for HPV self-sampling (between 3-30%) compared with Pap test reminder letters. We will conduct the first randomised trial in Australia comparing home-based HPV self-sampling with a reminder letter, to evaluate whether this improves participation and followup.
Related publications (4)
Women’s views on human papillomavirus self-sampling: focus groups to assess acceptability, invitation letters and a test kit in the Australian setting
Farhana Sultana, Robyn Mullins, Michael Murphy, Dallas R English, Julie A Simpson, Kelly T Drennan, Stella Heley, C David Wrede, Julia ML Brotherton, Marion Saville, Dorota M Gertig
<jats:p> Background The study evaluated acceptability, invitation letters and the test kit for a trial of human papillomavirus (..
Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia
Farhana Sultana, Dallas R English, Julie A Simpson, Julia ML Brotherton, Kelly Drennan, Robyn Mullins, Stella Heley, C David Wrede, Marion Saville, Dorota M Gertig